Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
BELLICUM PHARMACEUTICALS, INC (BLCM)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 01/20/2023 |
4/A
| Huber Reid M (Director) has filed a Form 4 on BELLICUM PHARMACEUTICALS, INC|
Txns:
| Exercised 80,968 shares
@ $0 |
|
| 01/04/2023 |
4/A
| Stonehouse Jon P (Director) has filed a Form 4 on BELLICUM PHARMACEUTICALS, INC|
Txns:
| Exercised 60,580 shares
@ $0 |
|
| 09/01/2022 |
4/A
| Stonehouse Jon P (Director) has filed a Form 4 on BELLICUM PHARMACEUTICALS, INC|
Txns:
| Exercised 21,054 restricted stock units
@ $0 |
|
| 08/18/2021 |
4/A
| Fair Richard A. (President and CEO) has filed a Form 4 on BELLICUM PHARMACEUTICALS, INC|
Txns:
| Granted 265,000 options to buy
@ $0 |
|
| 06/19/2015 |
4/A
| Spencer David M. (Chief Scientific Officer) has filed a Form 4 on BELLICUM PHARMACEUTICALS, INC|
Txns:
| Sold 17,200 shares
@ $22.8227, valued at
$392.6k
Sold 2,800 shares
@ $23.7939, valued at
$66.6k
|
|
|
|